4th Apr 2006 11:22
Bespak PLC04 April 2006 For immediate release 4 April 2006 Bespak plc ('the Company') Substantial Shareholding Bespak plc (LSE: BPK), a leader in specialty medical devices, reports, furtherto a letter dated 31 March 2006, that on 30 March 2006 Aviva PLC and itssubsidiaries sold 60,000 Ordinary Shares of 10 pence in the Company or 0.21% oftheir issued class. Following this transaction, Aviva PLC and its subsidiaries now own 1,365,647Ordinary Shares of 10 pence or 4.88% of their issued class as follows: Morley Fund Management LtdBNY Norwich Union Nominees Limited 236,747*Chase GA Group Nominees Limited 862,246*CUIM Nominee Limited 266,654* *(denotes beneficial interest) ENDS For further information please call: Bespak plcMark Throdahl - Chief Executive +44 (0) 20 1908 552 600Martin Hopcroft - Group Finance Director Buchanan Communications +44 (0) 20 7466 5000Tim Thompson / Mary-Jane Johnson / Elly Williamson Notes for Editors: About Bespak plc Bespak, a leader in specialty medical devices, develops delivery systems for thepharmaceutical industry and disposable airway management products for criticalcare settings. Bespak's product range includes metered dose and dry powderinhalers, actuators, inflation valves, disposable face masks, breathing circuitsand laryngeal tubes. The group, which has facilities in King's Lynn and MiltonKeynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on theOfficial List of the London Stock Exchange (LSE: BPK). For more information,please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.LAviva